Lupus & antiphospholipid syndrome

Stratification of primary antiphospholipid syndrome by mechanistic immunophenotype: machine learning identifies distinct T-cell and T-bet+CD11c+ B cell-driven patient clusters

Clin Exp RheumatolPublished Cross-sectional study

Authors' conclusion

Our findings suggest that pAPS is not a monolithic disorder but a heterogeneous syndrome composed of distinct, mechanistically-defined immunophenotypes.

Study context

Population
Patients with primary APS, healthy controls and healthy pregnant controls
Participants
54 / 26 / 16
Exposure
Primary antiphospholipid syndrome (pAPS) vs healthy controls (HC) and healthy pregnant (HP) controls
  • pAPSn = 54
  • HCn = 26reference
  • HPn = 16
Outcome
Distribution of 16 T and B cell subsets, focus on T-bet+CD11c+ B cells
Methodological detailsflow cytometry, exploratory machine learning-based K-means clustering
  • Flow cytometry
  • Exploratory machine learning-based K-means clustering

Main finding

As reported in the abstract

T-bet+CD11c+ B cell population

P < 0.01

Observational data: associations, not effects.

Further findings

OutcomeCluster K2Cluster K1
Immunophenotype clusters (K-means) and thrombosisExploratoryn = 17n = 19
Venous thrombosis41.2%— not stated in the abstract
Arterial thrombosis (highest rate)— not stated in the abstract31.6%

— not stated in the abstract

Immunophenotype clusters (K-means) and thrombosis

Three distinct immunophenotypes identified; K2 had the highest T-bet+CD11c+ B cell levels

T-bet+CD11c+ B cells vs anti-β2GP1 IgG titres in patients with thrombotic events

Positive correlation

Original publication

Stratification of primary antiphospholipid syndrome by mechanistic immunophenotype: machine learning identifies distinct T-cell and T-bet+CD11c+ B cell-driven patient clusters. Clin Exp Rheumatol. Published 24 November 2025. doi:10.55563/clinexprheumatol/3j9afb

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.